T2b至T4b期黑色素瘤初始分期中影像学检查的诊断准确性:横断面研究
该横断面研究纳入308例2009年AJCC临床分期T2b至T4b、无转移证据的黑色素瘤患者,评估4种影像学检查初始分期的诊断准确性。总体转移检出率为16.6%,假阳性率为5.8%。区域淋巴结超声在T2b及以上期别转移检出率为12.8%、准确率96.0%;T4b期CT与PET-CT转移检出率最高,脑MRI在T4b期转移检出率为2.0%。
要点
- T2b及以上期别黑色素瘤患者建议行区域淋巴结超声评估转移。
- T4b期患者适合采用CT或PET-CT检测转移。
- T4b期脑MRI对无症状患者的临床获益尚需进一步讨论。
核心结论
- 对AJCC T2b期及以上黑色素瘤患者,建议行超声扫描评估淋巴结转移。
- T4b期患者适合采用CT或PET-CT检测转移。
- T4b期脑MRI对无症状患者管理及治疗选择的最终临床获益尚需进一步讨论。
研究设计与样本
- 横断面研究,前瞻性收集2011年1月至2017年4月数据。
- 纳入按2009年AJCC临床分期为T2b至T4b、无转移证据的黑色素瘤患者308例。
- 评估4种影像学检查对黑色素瘤患者初始分期的诊断准确性。
主要发现
- 308例患者初始分期总体转移检出率为16.6%,假阳性率为5.8%。
- 区域淋巴结超声转移检出率为12.8%,假阳性率为0.8%,准确率为96.0%。
- T4b期CT转移检出率为13.3%,假阳性率为8.9%,准确率为91.1%。
- T4b期PET-CT转移检出率为6.9%,假阳性率为0%,准确率为93.1%。
- T4b期脑MRI转移检出率为2.0%。
关键数值与推荐
- 区域淋巴结超声:转移检出率12.8%,假阳性率0.8%,准确率96.0%。
- T4b期CT:转移检出率13.3%,假阳性率8.9%,准确率91.1%。
- T4b期PET-CT:转移检出率6.9%,假阳性率0%,准确率93.1%。
- T4b期脑MRI:转移检出率2.0%。
临床怎么用
- T2b期及以上黑色素瘤患者初始分期应行区域淋巴结超声评估淋巴结转移。
- T4b期患者可采用CT或PET-CT检测转移。
- T4b期脑MRI的应用需结合无症状患者的临床获益进一步权衡。
局限性
- 单中心研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is no consensus on the imaging tests that should be performed at the initial staging of melanoma patients. OBJECTIVE: To evaluate the diagnostic accuracy of 4 imaging studies for the initial staging of melanoma patients. METHODS: Cross-sectional study with prospectively collected data, from January 2011 to April 2017, including patients with clinical stage T2b to T4b according to 2009 American Joint Committee on Cancer, without evidence of metastasis. RESULTS: Initial staging of 308 patients detected 16.6% of metastases and 5.8% false-positive results, overall. Regional lymph node ultrasonography showed a metastasis detection rate (MDR) of 12.8%, false-positive rate of 0.8%, and accuracy of 96.0%. Computed tomography (CT) and positron emission tomography-CT had the highest detection rates at stage T4b: MDR, 13.3%; false-positive rate, 8.9%; accuracy, 91.1%; and MDR, 6.9%; false-positive rate, 0%; and accuracy, 93.1%, respectively. Brain magnetic resonance imaging showed a MDR of 2.0% in T4b. LIMITATIONS: Single-center study. CONCLUSION: Performing ultrasound scans for assessing lymph node metastasis in patients with American Joint Committee on Cancer T2b stage and above is advisable. In patients with stage T4b, CT or positron emission tomography-CT are suitable for the detection of metastasis. Brain magnetic resonance imaging at T4b deserves further discussion, considering the ultimate clinical benefit in management and therapeutic options for asymptomatic patients.
引用
- Riquelme-Mc Loughlin C, Podlipnik S, Bosch-Amate X, et al. Diagnostic accuracy of imaging studies for initial staging of T2b to T4b melanoma patients: A cross-sectional study. J Am Acad Dermatol. 2019. PMID: 31163236. doi:10.1016/j.jaad.2019.05.076
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。